Getting the knowledge to the patient

Calciscon Ltd., is a Swiss start-up company, which arose from the network of the NCCR Kidney.CH. Core business is the development and marketing of an in vitro diagnostic test for the early detection of calcification propensity in human blood.

Its co-founders are Dr Andreas Pasch, a researcher at the NCCR Kidney.CH, Prof. Willi Jahnen-Dechent from RWTH Aachen, Germany an expert in basic research on biomineralization, and Matthias Meier, former scientific project manager of the NCCR Kidney.CH.
The start of this tech-transfer-story ‘from bench to bedside’ has been promising: Calciscon has won several most prestigious start-up competitions. Its own labs have been established within the central lab facilities of University Hospital Bern, Inselspital.

For further information please follow the link:

Latest News

Farewell Symposium Fran├žois Verrey: Kidney & Transport

June 21, 2019
Zürich (USZ), Switzerland ...more


Please enter your E-Mail address here:

subscribe unsubscribe

Info Brochure

download (5mb)

Follow us on …


University of Zurich
Winterthurerstrasse 190
T: +41 44 635 52 16